Warning letter
Rehoboth Mckinley Christian Hospital: warning letter of Sep 28, 2000
FDA warning letter UCM078234 · Denver District Office
Key facts
| Reference number | UCM078234 |
|---|---|
| Company | Rehoboth Mckinley Christian Hospital |
| Subject | GMP for Blood & Blood Components/Adulterated |
| Issue date | Sep 28, 2000 |
| Posted date | Sep 28, 2000 |
| Issuing office | Denver District Office |
| Product type | Biologics |
| CFR sections cited | 606.20, 606.100, 606.60, 606.121 |
| Country | 3 |
| Inspection city | Gallup |
| Inspection ZIP | 87301-5683 |
| Inspection start date | Aug 3, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: